Agency for Healthcare Research and Quality – Federal Register Recent Federal Regulation Documents

Results 251 - 300 of 973
Devra Hamilton, N.P.; Decision and Order
Document Number: 2015-20348
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Jeffrey S. Holverson, M.D.; Decision and Order
Document Number: 2015-20346
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Drug Enforcement Administration
Document Number: 2015-20344
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality
Bulk Manufacturer of Controlled Substances Application: IRIX Manufacturing, Inc.
Document Number: 2015-20285
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Bulk Manufacturer of Controlled Substances Application: Austin Pharma LLC
Document Number: 2015-20284
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Bulk Manufacturer of Controlled Substances Application: Alltech Associates, Inc.
Document Number: 2015-20283
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Application: Cody Laboratories, Inc.
Document Number: 2015-20278
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Agency Information Collection Activities; Proposed eCollection eComments Requested; National Motor Vehicle Title Information System (NMVTIS)
Document Number: 2015-20048
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality
The Department of Justice, Office of Justice Programs, Bureau of Justice Assistance, will submit the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in 80 FR 32180, on June 5, 2015, allowing for a 60-day comment period.
Notice of Lodging of Proposed Consent Decree Under the Oil Pollution Act
Document Number: 2015-20215
Type: Notice
Date: 2015-08-17
Agency: Agency for Healthcare Research and Quality
Agency Information Collection Activities; Proposed eCollection eComments Requested; Approval of an Extension of a Currently Approved Collection; Request To Change III/NGI Base Identifier(s) (1-542)
Document Number: 2015-20128
Type: Notice
Date: 2015-08-17
Agency: Agency for Healthcare Research and Quality
The Department of Justice (DOJ), Federal Bureau of Investigation (FBI), Criminal Justice Information Services (CJIS) Division, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the 80 FR 33290, on June 11, 2015, allowing for a 60-day comment period.
Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection of Information; Beneficiary Referral Request
Document Number: 2015-20162
Type: Notice
Date: 2015-08-14
Agency: Agency for Healthcare Research and Quality
The Department of Justice (DOJ), Office of Justice Programs will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities: Proposed Collection, Comments Requested; Revision of a Currently Approved Collection; National Incident-Based Reporting System (NIBRS)
Document Number: 2015-19939
Type: Notice
Date: 2015-08-13
Agency: Agency for Healthcare Research and Quality
The Department of Justice, Federal Bureau of Investigation, Criminal Justice Information Services Division has submitted the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with established review procedures of the Paperwork Reduction Act of 1995.
Agency Information Collection Activities: Proposed eCollection, eComments Requested; Extension of a Currently Approved Collection Cargo Theft Incident Report
Document Number: 2015-19938
Type: Notice
Date: 2015-08-13
Agency: Agency for Healthcare Research and Quality
The Department of Justice, Federal Bureau of Investigation, Criminal Justice Information Services Division (CJIS) has submitted the following Information Collection Request to the Office of Management and Budget (OMB) for review and clearance in accordance with the established review procedures of the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Proposed Collection: Extension of Currently Approved Collection; Survey: National Corrections Reporting Program
Document Number: 2015-19909
Type: Notice
Date: 2015-08-13
Agency: Agency for Healthcare Research and Quality
The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at 80 FR 32607, on June 9, 2015, allowing for a 60 day comment period.
Agency Information Collection Activities; Proposed eCollection eComments Requested; 2016/2018 Identity Theft Supplement (ITS)
Document Number: 2015-19908
Type: Notice
Date: 2015-08-13
Agency: Agency for Healthcare Research and Quality
The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection; Comments Requested Research To Support the National Crime Victimization Survey (NCVS)
Document Number: 2015-19907
Type: Notice
Date: 2015-08-13
Agency: Agency for Healthcare Research and Quality
The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities: Proposed eCollection eComments Requested; Environmental Information
Document Number: 2015-19906
Type: Notice
Date: 2015-08-13
Agency: Agency for Healthcare Research and Quality
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the 80 FR 33291, on June 11, 2015, allowing for a 60 day comment period.
Webinar Meeting of the Federal Advisory Committee on Juvenile Justice
Document Number: 2015-19866
Type: Notice
Date: 2015-08-13
Agency: Agency for Healthcare Research and Quality, Federal Contract Compliance Programs Office
The Office of Juvenile Justice and Delinquency Prevention (OJJDP) has scheduled a webinar meeting of the Federal Advisory Committee on Juvenile Justice (FACJJ).
Notice of Lodging of Proposed Consent Decree Under the Clean Water Act
Document Number: 2015-19800
Type: Notice
Date: 2015-08-12
Agency: Agency for Healthcare Research and Quality
Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV
Document Number: 2015-19655
Type: Proposed Rule
Date: 2015-08-11
Agency: Agency for Healthcare Research and Quality, Agency for International Development
The Drug Enforcement Administration proposes to place the substance eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6- dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2- yl)ethyl]amino]methyl]-2-methoxybenzoic acid), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act (CSA). This proposed scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess), or propose to handle eluxadoline.
United States and State of New York v. Twin America, LLC, et al.; Public Comment and Response on Proposed Final Judgment
Document Number: 2015-19495
Type: Notice
Date: 2015-08-07
Agency: Agency for Healthcare Research and Quality, Government Ethics Office
Partnerships With Faith-Based and Other Neighborhood Organizations
Document Number: 2015-18259
Type: Proposed Rule
Date: 2015-08-06
Agency: Agency for Healthcare Research and Quality
The rule proposes to amend Department of Justice (Department) regulations on the equal treatment for faith-based or religious organizations and to implement Executive Order 13559 (Fundamental Principles and Policymaking Criteria for Partnerships With Faith-Based and Other Neighborhood Organizations). This rule proposes to revise Department regulations pertaining to prohibited religious uses of direct Federal financial assistance to provide clarity about the rights and obligations of faith-based and religious groups participating in Department programs and to provide protections for beneficiaries of those programs. The Department seeks public comments only on the proposed revisions that are being made to implement Executive Order 13559.
Manufacturer of Controlled Substances Registration: Patheon Pharmaceuticals, Inc.
Document Number: 2015-19173
Type: Notice
Date: 2015-08-05
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Patheon Pharmaceuticals, Inc. applied to be registered as a manufacturer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Patheon Pharmaceuticals, Inc. registration as a manufacturer of this controlled substance.
Manufacturer of Controlled Substances Registration: National Center for Natural Products Research (NIDA MPROJECT), Inc.
Document Number: 2015-19172
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
National Center for Natural Products Research (NIDA MPROJECT), Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants National Center for Natural Products Research (NIDA MPROJECT), Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc.
Document Number: 2015-19168
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Cody Laboratories, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cody Laboratories, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2015-19166
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Sigma Aldrich Research Biochemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma Aldrich Research Biochemicals, Inc. registration as a manufacturer of those controlled substances.
Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals, Inc.
Document Number: 2015-19165
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Registration: Meridian Medical Technologies
Document Number: 2015-19164
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Meridian Medical Technologies applied to be registered as an importer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Meridian Medical Technologies registration as an importer of this controlled substance.
Manufacturer of Controlled Substances Registration: Cayman Chemicals Company
Document Number: 2015-19163
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Cayman Chemicals Company applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cayman Chemicals Company registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Actavis Laboratories FL, Inc.
Document Number: 2015-19162
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Actavis Laboratories FL, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Actavis Laboratories FL, Inc., registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC
Document Number: 2015-19159
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC registration as an importer of those controlled substances.
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2015-19158
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Adeline Davies Essien, M.D.; Decision and Order
Document Number: 2015-19122
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Pedro E. Lopez, M.D.; Decision and Order
Document Number: 2015-19119
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
AIM Pharmacy & Surgical S. Corp. Order
Document Number: 2015-19116
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Manufacturer of Controlled Substances Registration: Cambrex Charles City
Document Number: 2015-19111
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Cambrex Charles City applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cambrex Charles City registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Almac Clinical Services Inc. (ACSI)
Document Number: 2015-19109
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Almac Clinical Services Inc. (ACSI) applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Almac Clinical Services Inc. (ACSI) registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Johnson Matthey, Inc.
Document Number: 2015-19107
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Johnson Matthey, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc., registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Hospira
Document Number: 2015-19106
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Hospira applied to be registered as an importer of certain basic class of controlled substances. The Drug Enforcement Administration (DEA) grants Hospira registration as an importer of this controlled substance.
Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc.
Document Number: 2015-19100
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Johnson Matthey, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Pharmacore, Inc.
Document Number: 2015-19099
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Pharmacore, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Pharmacore, Inc. registration as a manufacturer of those controlled substances.
Contraband and Inmate Personal Property: Technical Amendment
Document Number: 2015-18982
Type: Rule
Date: 2015-08-03
Agency: Agency for Healthcare Research and Quality, Merit Systems Protection Board
In this document, the Bureau of Prisons makes a minor technical amendment to its regulations on contraband and inmate personal property to maintain consistency in language which describes the purpose of the regulations as ensuring the safety, security, or good order of the facility or protection of the public.
Manufacturer of Controlled Substances Registration: Apertus Pharmaceuticals
Document Number: 2015-18695
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Apertus Pharmaceuticals applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Apertus Pharmaceuticals registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Cambridge Isotope Lab
Document Number: 2015-18693
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Cambridge Isotope Lab applied to be registered as a manufacturer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Cambridge Isotope Lab registration as a manufacturer of this controlled substance.
Manufacturer of Controlled Substances Registration: American Radiolabeled Chemicals, Inc.
Document Number: 2015-18692
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
American Radiolabeled Chemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants American Radiolabeled Chemicals, Inc. registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Stepan Company
Document Number: 2015-18691
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Stepan Company applied to be registered as an importer of certain basic class of controlled substances. The Drug Enforcement Administration (DEA) grants Stepan Company registration as an importer of this controlled substance.
Importer of Controlled Substances Registration: Pharmacore
Document Number: 2015-18690
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Pharmacore applied to be registered as an importer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Pharmacore registration as an importer of this controlled substance.
International Trade Data System Test-Voluntary Pilot Project
Document Number: 2015-18664
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Mississippi River Commission
Along with more than a dozen other agencies, the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) will participate in a U.S. Customs and Border Protection (CBP) pilot test of the International Trade Data System (ITDS) for processing import-related forms and data using the Partner Government Agency (PGA) Message Set and the Automated Commercial Environment (ACE). Industry participation in the pilot program is entirely voluntary. The pilot test will allow participating importers to submit forms and information to CBP through ACE for the purpose of obtaining CBP release and receipt. CBP will validate that information, and electronically transmit entry and release information to agencies (including ATF) for purposes of satisfying CBP's certification requirements. The pilot program seeks to streamline this part of the import process. Interested parties should regularly check the following Web site to confirm the list of participating ports: http://www.cbp.gov/document/guidance/list- aceitds-pga-message-set-pilot-ports. Information on ATF's rules and regulations, and answers to commonly asked questions, can be found on the agency's Web site: http://www.atf.gov.